A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brian Vickery, MD
Emory University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sydney Children'S Hospital
Randwick, New South Wales, Australia
- the Children'S Hospital at Westmead
Westmead, New South Wales, Australia
- Queensland Children'S Hospital
South Brisbane, Queensland, Australia
- Women'S and Children'S Hospital
North Adelaide, South Australia, Australia
- the Royal Children'S Hospital Melbourne
Parkville, Victoria, Australia
- Perth Children'S Hospital
Nedlands, Western Australia, Australia
- Arkansas Children'S Research Institute
Little Rock, Arkansas, United States
- Peninsula Research Associates
Rolling Hills Estates, California, United States
- Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
- Riley Children'S Hospital at Iu
Indianapolis, Indiana, United States
- Johns Hopkins Hospital
Baltimore, Maryland, United States
- Iaa Clinical Research
Chevy Chase, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Feb 2023
- Primary completion
- 30 Nov 2025
- Completion
- 30 Jun 2027
- Last update posted
- 15 Oct 2025
- Registered enrollment
- 90
- Registry id
- NCT05621317
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.